Ubrogepant
Ubrogepant (pronunciation: yoo-BROH-je-pant) is a medication used for the acute treatment of migraine with or without aura in adults. It is not used for the preventive treatment of migraines.
Etymology
The name "Ubrogepant" is derived from the chemical structure of the drug. The "Ubro" part of the name is a reference to the drug's chemical class, which is a type of G protein-coupled receptor antagonist. The "gepant" part of the name is a common suffix used for drugs in this class.
Pharmacology
Ubrogepant works by blocking the calcitonin gene-related peptide receptor (CGRP receptor), which is believed to play a crucial role in migraines. By blocking this receptor, Ubrogepant can prevent the onset of a migraine attack.
Usage
Ubrogepant is taken orally, with or without food. The recommended dose is 50 mg or 100 mg, depending on the severity of the migraine and the patient's response to the medication.
Side Effects
Common side effects of Ubrogepant include nausea, sleepiness, and dry mouth. Serious side effects are rare, but can include allergic reactions and liver problems.
Related Terms
See Also
External links
- Medical encyclopedia article on Ubrogepant
- Wikipedia's article - Ubrogepant
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski